Thema: Plättchenaggregationshemmung + orale Antikoagulation
ESC Leitlinie NSTEMI 09/2020
WOEST (What is the Optimal antiplatElet and anticoagulant therapy in patients with oral anticoagulation and coronary StenTing)
ISAR-TRIPLE (Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation)
PIONEER-AF PCI (Prevention of bleeding in patients with atrial fibrillation undergoing PCI)
AUGUSTUS (Antithrombotic Therapy after Acute Coronary Syndrome or PCI in Atrial Fibrillation)
RE-DUAL PCI (Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation)
ENTRUST-AF (Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation)